Thermo Fisher reported third-quarter 2026 results for the period ended September 26, 2026, with revenue up 9% to $12.14 billion and GAAP diluted EPS up 9% to $4.64. Organic revenue growth was 6%, and the company said it would give updated 2026 guidance on its earnings call that morning, so shareholders will get the outlook only through that call and not in this filing.
Revenue $12.14 billion, up from $11.12 billion a year earlier; organic growth 6%
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Thermo Fisher Scientific's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$44.56B
+3.9%
$17.74
+7.3%
15.0%
FY2024
$42.88B
+0.1%
$16.53
+7.0%
14.8%
FY2023
$42.86B
-4.6%
$15.45
-12.4%
14.0%
FY2022
$44.91B
+14.5%
$17.63
-9.4%
15.5%
FY2021
$39.21B
+21.7%
$19.46
+21.9%
19.7%
Frequently asked questions
When is Thermo Fisher Scientific's next earnings date?
Thermo Fisher Scientific has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Thermo Fisher Scientific earn last quarter?
For the quarter ended Sep 2026, Thermo Fisher Scientific reported diluted EPS of $4.64 (+8.7% year over year) on revenue of $12.14B (+9.1%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.